A statistically significant combination indicated a potentially HR subgroup in Ph‐like ALL, and all these combinations were merged into a new combination, namely CRLF2/EPOR/JAK2/p‐CRKL/p‐STAT5 combined with IKZF1 alterations. The gene discussed is JAK2; the disease is acute lymphoblastic leukemia.